Vladimir Aleksandrovich Kuksa

USPTO Granted Patents = 38 (Patent Applications = 9)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 182(Granted Patents)

Location History:

Kenmore, WA (US) (2011 - 2014)
Seattle, WA (US) (2012 - 2024)
Bothell, WA (US) (2014 - 2024)

Company Filing History:

University of Washington

patents

2 out of 2,311

University of Minnesota

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162871 - Inhibitors of VAP-1 (2024-12-10),

2. 12037334 - Inhibitors of VAP-1 (2024-07-16),

3. 12029708 - Alkoxy compounds for disease treatment (2024-07-09),

4. 11795136 - Methods for the treatment of diabetic retinopathy and other ophthalmic diseases (2023-10-24),

5. 11787791 - Inhibitors of VAP-1 (2023-10-17),

6. 11446261 - Alkoxy compounds for disease treatment (2022-09-20),

7. 10730825 - Methods for the treatment of diabetic retinopathy and other ophthalmic diseases (2020-08-04),

8. 10639286 - Alkoxy compounds for disease treatment (2020-05-05),

9. 10201545 - Styrenyl derivative compounds for treating ophthalmic diseases and disorders (2019-02-12),

10. 10188615 - Alkoxy compounds for disease treatment (2019-01-29),

11. 9957224 - Methods for the treatment of diabetic retinopathy and other ophthalmic diseases (2018-05-01),

12. 9907762 - Stabilized mutant opsin proteins (2018-03-06),

13. 9737496 - Alkoxy compounds for disease treatment (2017-08-22),

14. 9464033 - Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders (2016-10-11),

15. 9458088 - Alkoxy compounds for disease treatment (2016-10-04),

Title: Innovations and Contributions of Vladimir Aleksandrovich Kuksa in Ophthalmic Research

Introduction

Vladimir Aleksandrovich Kuksa is an accomplished inventor based in Bothell, Washington, with a remarkable portfolio of 36 patents to his name. His work primarily focuses on the development of innovative treatments for various ophthalmic diseases, showcasing a dedication to advancing medical science.

Latest Patents

Kuksa’s latest patents include significant advancements such as inhibitors of VAP-1. These compounds and methods are designed for modulation of VAP-1 activity, emphasizing their importance in treating related conditions. Another notable patent addresses methods for the treatment of diabetic retinopathy and other ophthalmic diseases. This patent outlines techniques for managing ophthalmic disorders associated with diabetes and includes methodologies for treating retinopathy of prematurity and wet age-related macular degeneration, highlighting his commitment to improving patient outcomes.

Career Highlights

Throughout his career, Kuksa has made significant contributions to the field of ophthalmology while working with reputable organizations such as Acucela Inc. and the University of Washington. His work in these institutions has reinforced his status as a pioneering inventor dedicated to the research and development of effective treatments.

Collaborations

Kuksa has collaborated with esteemed professionals like Mark W. Orme and Ian L. Scott, further enhancing the quality and impact of his innovations. These partnerships have contributed to a richer exchange of ideas and expertise, fostering advancements in ophthalmic research.

Conclusion

Vladimir Aleksandrovich Kuksa stands out as a prominent figure in the field of ophthalmic innovations, with a strong focus on impactful treatments for serious eye conditions. His extensive patent portfolio and collaborative efforts demonstrate his commitment to improving healthcare through innovative inventions and methodologies.

This text is generated by artificial intelligence and may not be accurate.